304 related articles for article (PubMed ID: 28532539)
21. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
23. Exploratory study on application of MALDI‑TOF‑MS to detect serum and urine peptides related to small cell lung carcinoma.
Lv P; Liu Z; Xu B; Tang C; Li X; Qin H; Yang S; Gao H; He K; Liu X
Mol Med Rep; 2020 Jan; 21(1):51-60. PubMed ID: 31746355
[TBL] [Abstract][Full Text] [Related]
24. Matrix-assisted laser desorption ionization: time of flight mass spectrometry-identified models for detection of ESBL-producing bacterial strains.
Li B; Guo T; Qu F; Li B; Wang H; Sun Z; Li X; Gao Z; Bao C; Zhang C; Li X; Mao Y
Med Sci Monit Basic Res; 2014 Nov; 20():176-83. PubMed ID: 25390932
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
Li DX; Chen XB
Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of platinum-containing doublet chemotherapy and liposome paclitaxel monotherapy for the treatment of elderly patients with advanced non-small cell lung cancer].
Wang C; Zhou L; Liu YM; Ding ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):685-8. PubMed ID: 24059133
[TBL] [Abstract][Full Text] [Related]
27. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
28. Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
Salmon S; Chen H; Chen S; Herbst R; Tsao A; Tran H; Sandler A; Billheimer D; Shyr Y; Lee JW; Massion P; Brahmer J; Schiller J; Carbone D; Dang TP
J Thorac Oncol; 2009 Jun; 4(6):689-96. PubMed ID: 19404214
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.
Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF
Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732
[TBL] [Abstract][Full Text] [Related]
30. Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.
Tao YL; Li Y; Gao J; Liu ZG; Tu ZW; Li G; Xu BQ; Niu DL; Jiang CB; Yi W; Li ZQ; Li J; Wang YM; Cheng ZB; Liu QD; Bai L; Zhang C; Zhang JY; Zeng MS; Xia YF
J Cell Biochem; 2012 Jul; 113(7):2268-78. PubMed ID: 22334501
[TBL] [Abstract][Full Text] [Related]
31. MMP-9/ANC score as a predictive biomarker for efficacy of bevacizumab plus platinum doublet chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer.
Hiura K; Shiraishi A; Suzuki C; Takamura K; Yamamoto M; Komori H; Watanabe Y; Iwaki-Egawa S
Cancer Biomark; 2015; 15(4):433-40. PubMed ID: 25835177
[TBL] [Abstract][Full Text] [Related]
32. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
[TBL] [Abstract][Full Text] [Related]
33. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
[TBL] [Abstract][Full Text] [Related]
35. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
36. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
[TBL] [Abstract][Full Text] [Related]
37. [Establishment of diagnostic model to monitor minimal residual disease of acute promyelocytic leukemia by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry].
Zhang LL; Xu ZF; Tan YH; Chen XH; Xu AN; Ren FG; Wang HW
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):16-20. PubMed ID: 23597458
[TBL] [Abstract][Full Text] [Related]
38. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
39. Detection and significance of serum protein markers of small-cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
[TBL] [Abstract][Full Text] [Related]
40. [Proteomic Analysis of Rat Brain Stem with DAI by MALDI-TOF-MS].
Ren GH; Liu NG; Chen YJ; Shi Y; Zou DH; Huang P; Li ZD; Sha HY; Deng KF
Fa Yi Xue Za Zhi; 2016 Feb; 32(1):13-7. PubMed ID: 27295850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
